Literature DB >> 6589586

Urinary potassium excretion in the critically ill neonate.

W D Engle, B S Arant.   

Abstract

The possibility that negative potassium balance may occur in critically ill preterm neonates is suggested by factors such as the usual provision of minimal potassium intake, increased plasma aldosterone concentrations, increased prostaglandin synthesis, and the frequent use of diuretic agents. In order to assess the relationship between potassium balance and renal prostaglandins, nine infants with respiratory distress syndrome (mean birth weight 1,264 g, mean gestational age 30.6 weeks) were studied sequentially with timed-urine collections during the first four postnatal days and values were compared with those of 18 preterm infants without respiratory distress syndrome. Mean plasma potassium concentrations decreased significantly from 4.87 +/- 0.19 mEq/L (mean +/- SEM) on day 1 to 3.83 +/- 0.18 mEq/L on day 4, (P less than 0.05), and cumulative potassium balance was -4.07 +/- 0.95 mEq/kg or 10% of estimated total body potassium. Urinary excretion of prostaglandin E2 on day 1 in infants with respiratory distress syndrome was significantly greater than in those without respiratory distress syndrome (22.0 +/- 4.9 v 8.3 +/- 1.6 ng/mg of creatinine) (r = .66, P less than .001). These studies suggest that consideration be given to the importance of providing sufficient potassium to prevent hypokalemia in the stressed preterm infant and that pharmacologic agents that alter prostaglandins or potassium excretion should be used with caution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6589586

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  2 in total

Review 1.  Management of fluid and electrolyte therapy in the newborn.

Authors:  E G John
Journal:  Indian J Pediatr       Date:  1988 Nov-Dec       Impact factor: 1.967

2.  Renal function in sick very low birthweight infants: 3. Sodium, potassium, and water excretion.

Authors:  B H Wilkins
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.